Injectable Drug Delivery Market Size Worth USD 27.8 Billion, Globally, by 2028 at 8.8% CAGR – Injectable Drug Delivery Industry Report by Vantage Market Research


WASHINGTON, July 18, 2022 (GLOBE NEWSWIRE) -- In recent years, the growing prevalence of chronic diseases and rise in the use of biological components is driving the Injectable Drug Delivery Market. This lifestyle change is the primary factor responsible for the increase in obesity rates, leading to many chronic diseases such as diabetes and cardiovascular disorders. The Global Market revenue stood at a value USD 16.8 Billion in 2021.

The Global Injectable Drug Delivery Market size is forecasted to reach USD 27.8 Billion by the year 2028 and is expected to grow to exhibit a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period; states Vantage Market Research, in a report, titled “Injectable Drug Delivery Market Size, Share & Trends Analysis Report by Type (Devices, Formulations), by Formulation Packaging (Ampules, Vials, Cartridges, Bottles), by Application (Auto-Immune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), by Usage Pattern (Curative Care, Immunization), by Site of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), by Distribution Channel (Hospitals, Retail Pharmacy Stores), by Facility of Use (Hospitals & Clinics, Home Care Settings), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/injectable-drug-delivery-market-1741/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)   

  • The newly updated, 140+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
  • We offer these reports in PDF format so you can read them on your computer and print them out.
  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

Key Insights & Findings from the Report:

  • According to our primary respondents’ research, the Injectable Drug Delivery market is predicted to grow at a CAGR of roughly 8.8% during the forecast period.
  • The Injectable Drug Delivery market was estimated to be worth roughly USD 16.8 Billion in 2021 and is expected to reach USD 27.8 Billion by 2028; based on primary research.   
  • On the basis of region, Asia Pacific is projected to dominate the worldwide Injectable Drug Delivery market.

Market Dynamics:

Drivers:

Increasing Patient demand for Ready-to-use (pre-filled), Reusable Syringes and Devices to the Drive Market Growth

Traditional drug delivery vials and syringes are prone to dosing and handling errors and a significant risk of infection. Alternatively, pre-filled syringes and reusable glass syringes, safe and highly effective medication delivery to the body, can be used to reduce this risk. The global market is growing because of increasing patient awareness and interest in a convenient and minimally invasive route of injectable drug delivery. Furthermore, the global injectable drug delivery market is driven by the advent of low-cost systems due to their effectiveness, on-target delivery, and ease. Again, the rapid growth of healthcare infrastructure and increasing innovations for developing novel drug delivery systems are expected to enhance product sales, aiding in the market's rise during the forecast period.

Growing Geriatric Population to Drive the Market's Growth

The growing geriatric population is driving the global injectable medicine delivery industry. A larger supply of generic drugs and dosages is required for the senior population. In addition, growing older brings a host of diseases, resulting in a surge in the drug delivery industry. Furthermore, the growing global biologics and biosimilar markets will significantly impact the growth of the injectable drug delivery market. In addition, expanding urbanization and disposable income are driving factors propelling the injectable medicine delivery industry forward. In addition, changing lifestyles and rising healthcare infrastructure spending are two essential industry drivers that will accelerate the growth of the injectable medication delivery market. Furthermore, increasing research and development activities would create good growth possibilities in the injectable medication delivery industry. Furthermore, during the projected period, enhancements in prod drug implants, chip-based drug delivery, and technological advancement would create good possibilities for injectable drug delivery market expansion.

Purchase This Premium Report (Price 4500 USD for a single-user license) at @ https://www.vantagemarketresearch.com/buy-now/injectable-drug-delivery-market-1741/0

Benefits of Purchasing Injectable Drug Delivery Market Reports:              

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Segmentation of the Global Injectable Drug Delivery Market:

  • Type
    • Devices
    • Formulations
  • Formulation Packaging
    • Ampules
    • Vials
    • Cartridges
    • Bottles
  • Application
    • Auto-Immune Diseases
    • Hormonal Disorders
    • Orphan Diseases
    • Oncology
    • Other Applications
  • Usage Pattern
    • Curative Care
    • Immunization
    • Other Patterns
  • Site of Administration
    • Skin
    • Circulatory/Musculoskeletal
    • Organs
    • Central Nervous System
  • Distribution Channel
    • Hospitals
    • Retail Pharmacy Stores
  • Facility of Use
    • Hospitals & Clinics
    • Home Care Settings
    • Other Facilities of Use
  • Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/injectable-drug-delivery-market-1741

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the healthcare industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

The Report on Injectable Drug Delivery Market Highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Historic Data, Estimates, and Forecast
  • Company Profiles
  • Global and Regional Dynamics

Browse market data Tables and Figures spread through 142 Pages and in-depth TOC on "Injectable Drug Delivery Market Size, Share & Trends Analysis Report by Type (Devices, Formulations), by Formulation Packaging (Ampules, Vials, Cartridges, Bottles), by Application (Auto-Immune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), by Usage Pattern (Curative Care, Immunization), by Site of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), by Distribution Channel (Hospitals, Retail Pharmacy Stores), by Facility of Use (Hospitals & Clinics, Home Care Settings), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Regional Analysis:

North America Dominated the Global Injectable Drug Delivery Market

North America dominated the global Injectable Drug Delivery Market in 2021. This is attributable to the increased adoption of novel injectable medication delivery systems among diabetes, cancer, and other autoimmune patients. Due to increased consciousness of these delivery systems, a larger patient pool, and a change from conventional drug delivery injection to ready-to-use injectable, the market in the region.

List of Prominent Players in Injectable Drug Delivery Market:

  • Becton Dickinson & Company (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Eli Lilly & Company (U.S.)
  • Baxter International Inc. (U.S.)
  • Schott AG (Germany)
  • Gerresheimer (Germany)
  • Ypsomed (Switzerland)
  • B. Braun Melsungen (Germany)

Recent Developments:

March 2020: Becton, Dickinson, and Company (BD) announced that the 50-subject human clinical trial for their experimental device, the BD Libertas Wearable Injector, was completed successfully.

April 2020: The AJOVY auto-injector was been commercially introduced in the United States, according to TEVA Pharmaceuticals USA, Inc. This device is designed to treat migraines in adults as a preventative measure.

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Injectable Drug Delivery Market?
  • How will the Injectable Drug Delivery Market change in the upcoming six years?
  • Which application and product will take a lion’s share of the Injectable Drug Delivery Market?
  • What is the Injectable Drug Delivery market drivers and restrictions?
  • What will be the CAGR and size of the Injectable Drug Delivery Market throughout the forecast period?    

This market titled “Injectable Drug Delivery Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

ParameterDetails
Market Size Provided for Years2016-2028
Base Year2021
Historic Years2016-2020
Forecast Years2022-2028
Segments Covered• Type

   • Devices

   • Formulations

• Formulation Packaging

   • Ampules

   • Vials

   • Cartridges

   • Bottles

• Application

   • Auto-Immune Diseases

   • Hormonal Disorders

   • Orphan Diseases

   • Oncology

   • Other Applications

• Usage Pattern

   • Curative Care

   • Immunization

   • Other Patterns

• Site of Administration

   • Skin

   • Circulatory/Musculoskeletal

   • Organs

   • Central Nervous System

• Distribution Channel

   • Hospitals

   • Retail Pharmacy Stores

• Facility of Use

   • Hospitals & Clinics

   • Home Care Settings

   • Other Facilities of Use

• Region

   • North America

   • Europe

   • Asia Pacific

   • Latin America

   • Middle East & Africa

Region & Counties Covered• North America

    • U.S.

    • Canada

    • Mexico

• Europe

    • U.K

    • France

    • Germany

    • Italy

    • Spain

    • Rest Of Europe

• Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • South East Asia

    • Rest Of Asia Pacific

• Latin America

    • Brazil

    • Argentina

    • Rest Of Latin America

• Middle East & Africa

    • GCC Countries

    • South Africa

    • Rest Of Middle East & Africa
Companies Covered• Becton Dickinson & Company (U.S.)

• Pfizer Inc. (U.S.)

• Teva Pharmaceuticals Industries Ltd. (Israel)

• Eli Lilly & Company (U.S.)

• Baxter International, Inc. (U.S.)

• Schott AG (Germany)

• Gerresheimer (Germany)

• Ypsomed (Switzerland)

• B. Braun Melsungen (Germany)
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis,
PEST analysis, value chain analysis, regulatory landscape, technology
landscape, patent analysis, market attractiveness analysis by segments
and North America, company market share analysis, and COVID-19 impact analysis

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/injectable-drug-delivery-market-1741/request-sample

Browse More Related Report:              

  • Cat Allergy in Humans Market Size, Share & Trends Analysis Report by Treatment (Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors), by Application (Allergy Treatment, Allergy Prevention), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
  • Accountable Care Solutions Market Size, Share & Trends Analysis Report by Product & Service (Healthcare Provider Solutions, Healthcare Payer Solutions, Services), by Delivery Mode (Web & Cloud-Based Delivery Mode, On-Premise Delivery Mode), by End User (Healthcare Providers, Healthcare Payers), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
  • Medical Waste Management Market Size, Share & Trends Analysis Report by Service (Collection, Transportation, & Storage Services, Treatment & Disposal Services, Recycling Services), by Type of Waste (Non-Hazardous Waste, Hazardous Waste), by Treatment Site (Offsite Treatment, Onsite Treatment), by Waste Generator (Hospitals & Diagnostic Laboratories, Other Waste Generators), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).
  • Healthcare Analytics Market Size, Share & Trends Analysis Report by Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, Cognitive Analytics), by Application (Clinical Analytics, Financial Analytics, Operation and Administrative Analytics, Population Health), by Component (Services, Hardware, Software), by Deployment Model (On-Premise, On-Demand), by End User (Payers, Providers, ACOs, HIEs, Mcos and TPAs), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028).

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research reports. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.   

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs

Blog: